ANNOUNCEMENT

Save $300 on MedCity CONVERGE Healthcare Innovation Summit July 9-10 in Philadelphia. Earlybird rate ends May 20.

Biotechnology firm acquires imaging technology license to improve acute coronary syndrome diagnosis

Biotechnology firm acquires imaging technology license to improve acute coronary syndrome diagnosis

August 1, 2012 8:41 pm by | 0 Comments

A biotechnology company’s licensing deal for a radiopharmaceutical could make it easier to diagnoseacute coronary syndrome in cases that might otherwise go undiagnosed or be diagnosed too late.Molecular Targeting Technologies ... Read more